LINGUAMATICS ANNOUNCES UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM AS LATEST ENTERPRISE NLP CLIENT

June 22, 2017

I2E Natural Language Processing advances research and care delivery by mining clinical insights from unstructured patient data
CAMBRIDGE, UNITED KINGDOM - Jun 22, 2017 -

- Market leading Natural Language Processing (NLP) text analytics provider Linguamatics today announced the implementation of the Linguamatics Health enterprise NLP platform, powered by I2E, at the University of Pennsylvania Health System for the extraction of actionable insights from unstructured patient data.

“We look forward to working with Penn Medicine to help them unlock valuable insights from clinical notes in order to advance research initiatives and enhance the delivery of care,” said Simon Beaulah, senior director of healthcare at Linguamatics. “Our growing community of academic medical centers across the country have deployed the Linguamatics Health platform, and are taking advantage of its ease of use, powerful NLP capabilities, rapid query development and successful integration with enterprise systems. Our platform is particularly well-suited for this environment because it empowers organizations to work independently, and get the data they want without requiring extensive services.”  

The University of Pennsylvania Health System will leverage the Linguamatics Health platform to build queries and automatically mine clinical data from patient encounter records, specialist reports and unstructured EHR notes. Specific use cases will include the identification of cohorts of patients with certain medical conditions and locating additional clinical annotations for the PennOmics system for translational research.

“Our organization needed an NLP tool to make unstructured clinical data more accessible for our research and clinical efforts,” said Jason Moore, director of the Penn Institute for Biomedical Informatics (IBI). “We look forward to exploring different opportunities to use Linguamatics I2E’s NLP capabilities to gain additional insights from our unstructured patient data.”

ENDS

 

About Linguamatics

Linguamatics transforms unstructured big data into big insights to advance human health and wellbeing. A world leader in deploying innovative natural language processing (NLP)-based text mining for high-value knowledge discovery and decision support, Linguamatics’ solutions are used by top commercial, academic and government organizations, including 18 of the top 20 global pharmaceutical companies, and leading US healthcare organizations.

Linguamatics I2E is used to mine a wide variety of text resources, such as scientific literature, patents, Electronic Health Records (EHRs), clinical trials data, news feeds, social media and proprietary content. I2E can be deployed as an in-house enterprise system, or as Software-as-a-Service (SaaS) on the cloud. For more information, visit linguamatics.com and follow @Linguamatics on Twitter.

 
For further information please contact:

Michelle Ronan Noteboom, Sr. Account Director
Amendola Communications
+ 1 512.426.2870
mnoteboom@acmarketingpr.com 

 
LINGUAMATICS ANNOUNCES UNIVERSITY OF PENNSYLVANIA HEALTH SYSTEM AS LATEST ENTERPRISE NLP CLIENT

I2E Natural Language Processing advances research and care delivery by mining clinical insights from unstructured patient data


(Cambridge, England and Boston, USA - June 22, 2017) 

- Market leading Natural Language Processing (NLP) text analytics providerLinguamatics today announced the implementation of the Linguamatics Health enterprise NLP platform, powered by I2E, at the University of Pennsylvania Health System for the extraction of actionable insights from unstructured patient data.

“We look forward to working with Penn Medicine to help them unlock valuable insights from clinical notes in order to advance research initiatives and enhance the delivery of care,” said Simon Beaulah, senior director of healthcare at Linguamatics. “Our growing community of academic medical centers across the country have deployed the Linguamatics Health platform, and are taking advantage of its ease of use, powerful NLP capabilities, rapid query development and successful integration with enterprise systems. Our platform is particularly well-suited for this environment because it empowers organizations to work independently, and get the data they want without requiring extensive services.”  

The University of Pennsylvania Health System will leverage the Linguamatics Health platform to build queries and automatically mine clinical data from patient encounter records, specialist reports and unstructured EHR notes. Specific use cases will include the identification of cohorts of patients with certain medical conditions and locating additional clinical annotations for the PennOmics system for translational research.

“Our organization needed an NLP tool to make unstructured clinical data more accessible for our research and clinical efforts,” said Jason Moore, director of the Penn Institute for Biomedical Informatics (IBI). “We look forward to exploring different opportunities to use Linguamatics I2E’s NLP capabilities to gain additional insights from our unstructured patient data.”

ENDS

 

About Linguamatics

Linguamatics transforms unstructured big data into big insights to advance human health and wellbeing. A world leader in deploying innovative natural language processing (NLP)-based text mining for high-value knowledge discovery and decision support, Linguamatics’ solutions are used by top commercial, academic and government organizations, including 18 of the top 20 global pharmaceutical companies, and leading US healthcare organizations.

Linguamatics I2E is used to mine a wide variety of text resources, such as scientific literature, patents, Electronic Health Records (EHRs), clinical trials data, news feeds, social media and proprietary content. I2E can be deployed as an in-house enterprise system, or as Software-as-a-Service (SaaS) on the cloud. For more information, visit linguamatics.com and follow @Linguamatics on Twitter.

 
For further information please contact:

Michelle Ronan Noteboom, Sr. Account Director
Amendola Communications
+ 1 512.426.2870
mnoteboom@acmarketingpr.com